Coronary stenting with MGuard: from conception to human trials.
about
No-reflow phenomenon: pathophysiology, diagnosis, prevention, and treatment. A review of the current literature and future perspectives.Alternative stents in ST-segment elevation myocardial infarction: improving the efficacy of primary percutaneous coronary intervention.Multicentre experience with MGuard net protective stent in ST-elevation myocardial infarction: safety, feasibility, and impact on myocardial reperfusion.Real world comparison of the MGuard Stent versus the bare metal stent for ST elevation myocardial infarction (the REWARD-MI study).MGuard mesh-covered stent for treatment of ST-segment elevation myocardial infarction with high thrombus burden despite manual aspiration.MGUard versus bAre-metal stents plus manual thRombectomy in ST-elevation myocarDial infarction pAtieNts-(GUARDIAN) trial: study design and rationale.
P2860
Coronary stenting with MGuard: from conception to human trials.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Coronary stenting with MGuard: from conception to human trials.
@en
Coronary stenting with MGuard: from conception to human trials.
@nl
type
label
Coronary stenting with MGuard: from conception to human trials.
@en
Coronary stenting with MGuard: from conception to human trials.
@nl
prefLabel
Coronary stenting with MGuard: from conception to human trials.
@en
Coronary stenting with MGuard: from conception to human trials.
@nl
P1476
Coronary stenting with MGuard: from conception to human trials
@en
P2093
Marc Klapholz
Steve Tsai
P356
10.1016/J.CARREV.2007.12.002
P50
P577
2008-04-01T00:00:00Z